These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8781979)

  • 21. Lactosylceramide stimulates aortic smooth muscle cell proliferation.
    Chatterjee S
    Biochem Biophys Res Commun; 1991 Dec; 181(2):554-61. PubMed ID: 1755837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.
    Felding-Habermann B; Igarashi Y; Fenderson BA; Park LS; Radin NS; Inokuchi J; Strassmann G; Handa K; Hakomori S
    Biochemistry; 1990 Jul; 29(26):6314-22. PubMed ID: 2207076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts.
    Uemura K; Sugiyama E; Tamai C; Hara A; Taketomi T; Radin NS
    J Biochem; 1990 Oct; 108(4):525-30. PubMed ID: 2149853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized low density lipoproteins and lactosylceramide both stimulate the expression of proliferating cell nuclear antigen and the proliferation of aortic smooth muscle cells.
    Chatterjee S
    Indian J Biochem Biophys; 1997; 34(1-2):56-60. PubMed ID: 9343929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.
    Burger KN; van der Bijl P; van Meer G
    J Cell Biol; 1996 Apr; 133(1):15-28. PubMed ID: 8601603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of [(3)H]thymidine transport is a nonspecific effect of PDMP in primary cultures of mouse epidermal keratinocytes.
    Griner RD; Bollag WB
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1219-24. PubMed ID: 10945880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A truncated epoxy-glucosylceramide uncouples glycosphingolipid biosynthesis by decreasing lactosylceramide synthase activity.
    Zacharias C; van Echten-Deckert G; Plewe M; Schmidt RR; Sandhoff K
    J Biol Chem; 1994 May; 269(18):13313-7. PubMed ID: 8175761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids.
    Alam S; Fedier A; Kohler RS; Jacob F
    Glycobiology; 2015 Apr; 25(4):351-6. PubMed ID: 25715344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactosylceramide is required in apoptosis induced by N-Smase.
    Martin SF; Williams N; Chatterjee S
    Glycoconj J; 2006 May; 23(3-4):147-57. PubMed ID: 16691498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells.
    Mutoh T; Tokuda A; Inokuchi J; Kuriyama M
    J Biol Chem; 1998 Oct; 273(40):26001-7. PubMed ID: 9748278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases.
    Rani CS; Abe A; Chang Y; Rosenzweig N; Saltiel AR; Radin NS; Shayman JA
    J Biol Chem; 1995 Feb; 270(6):2859-67. PubMed ID: 7852361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues.
    Chatterjee SB; Dey S; Shi WY; Thomas K; Hutchins GM
    Glycobiology; 1997 Feb; 7(1):57-65. PubMed ID: 9061365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
    Mishra S; Bedja D; Amuzie C; Avolio A; Chatterjee S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):159-64. PubMed ID: 26253472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.
    Abe A; Radin NS; Shayman JA; Wotring LL; Zipkin RE; Sivakumar R; Ruggieri JM; Carson KG; Ganem B
    J Lipid Res; 1995 Mar; 36(3):611-21. PubMed ID: 7775872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in composition of newly synthesized sphingolipids of HeLa cells during the cell cycle -- suppression of sphingomyelin and higher-glycosphingolipid synthesis and accumulation of ceramide and glucosylceramide in mitotic cells.
    Yokoyama K; Suzuki M; Kawashima I; Karasawa K; Nojima S; Enomoto T; Tai T; Suzuki A; Setaka M
    Eur J Biochem; 1997 Oct; 249(2):450-5. PubMed ID: 9370353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
    Wang T; Wei J; Wang N; Ma JL; Hui PP
    Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
    Bieberich E; Freischütz B; Suzuki M; Yu RK
    J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells.
    Rajesh M; Kolmakova A; Chatterjee S
    Circ Res; 2005 Oct; 97(8):796-804. PubMed ID: 16151023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic ceramide analog (L-PDMP) up-regulates neuronal function.
    Inokuchi J; Mizutani A; Jimbo M; Usuki S; Yamagishi K; Mochizuki H; Muramoto K; Kobayashi K; Kuroda Y; Iwasaki K; Ohgami Y; Fujiwara M
    Ann N Y Acad Sci; 1998 Jun; 845():219-24. PubMed ID: 9668355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.